Advanced Search
JIANG Lin, KONG Qing-zhi, HU Xian-zhu. Clinical Analysis of Whole Body Gamma Knife Combined with DP Regimen for Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(12): 1431-1433. DOI: 10.3971/j.issn.1000-8578.2011.12.024
Citation: JIANG Lin, KONG Qing-zhi, HU Xian-zhu. Clinical Analysis of Whole Body Gamma Knife Combined with DP Regimen for Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(12): 1431-1433. DOI: 10.3971/j.issn.1000-8578.2011.12.024

Clinical Analysis of Whole Body Gamma Knife Combined with DP Regimen for Advanced Non-small Cell Lung Cancer

More Information
  • Received Date: February 27, 2011
  • Revised Date: July 12, 2011
  • ObjectiveTo observe the short-term curative effects of whole body gamma knife combined with concurrent chemotherapy for treatment of advanced non-small cell lung cancer(NSCLC) . Methods All 120 patients were treated with whole body gamma knife combined with concurrent chemotherapy.Radiation was delivered in 10 to 14 fractions with a cumulated marginal dose ranged 35~45 Gy.DP project were given with whole body gamma knife,28d per cycle.At least 2 cycles were delivered.Clinical effects were evaluated 3 months after whole body gamma knife treatment. Results The total efficacy rate was 85.00% ( 102/120 ) .Acute radiation induced lung injury was 5.83% (7/120)(Ⅰ~Ⅱ) ; acute radiation induced esophagus injury was 4.17% (5/120)( Ⅰ~Ⅱ) ; bone marrow toxicity 12.50% (Ⅲ).In the follow up of 24 months,the survival rates at 6,12 and 24 months were 85.83% (103/120),54.17% (65/120) and 39.17%(47/120),respectively. Conclusion Whole body gamma knife combined with concurrent chemotherapy is a feasible,safe,and effective method and could be well tolerated in most patients.It is a good treatment for patients with advanced lung cancer and deserves further investigation.
  • Related Articles

    [1]LIN Jinlan, GUO Tianxing, PAN Xiaojie, XU Zhenwu. Clinical Observation of Metronomic Oral Vinorelbine Monotherapy as First-line Treatment on Elderly Patients with Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2018, 45(11): 909-912. DOI: 10.3971/j.issn.1000-8578.2018.18.0841
    [2]CHEN Pengcheng, MAO Weimin. Clinical Investigation on Qingfei Mixture Combined with Chemotherapy on Middle and Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2016, 43(7): 609-615. DOI: 10.3971/j.issn.1000-8578.2016.07.014
    [3]Liu Mingyue, Hou Guiqin, Gao Tianhui, Cui Yao, Li Xiaoyan, Zhou Yun. Efficacy of Pemetrexed Chemotherapy in Advanced Non-small Cell Lung Cancer with EGFR-TKI Resistence[J]. Cancer Research on Prevention and Treatment, 2012, 39(06): 713-715. DOI: 10.3971/j.issn.1000-8578.2012.06.025
    [4]Tong Wanning, Zhang Jun, Zhuo Anshan, Cao Yushu. Clinical Effects of Whole Body Gamma Knife Combined with Pemetrexed Plus Carboplatin on Concurrent Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(01): 81-84. DOI: 10.3971/j.issn.1000-8578.2012.01.021
    [5]WANG Ya-di, HA Min-wen, AN Yu-zhi, WANG Yue, CHENG Jian, LIU Wei. Clinical Observation of Gemcitabine Monotherapy in Treatment of Elder Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(06): 698-700. DOI: 10.3971/j.issn.1000-8578.2011.06.025
    [6]TAO Dan, LONG Zhi-xiong, WANG Bin, LIU Yan-ping, GAO Xia, HUANG Ya-li, WU Jing, HUANG Hui, WAN Huan. Clinical Effects of Accelerator Linear Plus Gamma Knife Radiotherapy Combined with Concurrent DP Regimen Chemotherapy for Locally Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(05): 575-578. DOI: 10.3971/j.issn.1000-8578.2011.05.026
    [7]ZHAN Yong-zi, HUANG Chang-jie, HUANG Jian-feng. Clinical Observation of Erlotinib in Treatment of Patients with Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2010, 37(04): 461-462. DOI: 10.3971/j.issn.1000-8578.2010.04.025
    [8]FU Xiao-min, WANG Jing, ZHANG Hui, BAO Ai-hua. Clinical Research for Docetaxel Plus Cisplatin in Untreated Adwanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 205-208. DOI: 10.3971/j.issn.1000-8578.2010.02.022
    [9]LI Hong-mei, GAO Ya-ling. Clinical Comparison of Three Different Chemotherapy Regimens Including Cisplain for Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2006, 33(09): 670-672. DOI: 10.3971/j.issn.1000-8578.1314
    [10]PAN Da-chao, XIE ZHong. The clinical study of combination chemotherapy with navelbine and ifosfamide in treating of advanced Non-small cell lung cancer[J]. Cancer Research on Prevention and Treatment, 2002, 29(03): 241-242. DOI: 10.3971/j.issn.1000-8578.3085

Catalog

    Article views (2186) PDF downloads (283) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return